SCHEMBL825301

SCHEMBL825301

C=C(C)C(=O)OCc1cc(C)cc(/N=N/c2ccc(OC)cc2)c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 10/20 0.49
▸ MAPK1 P28482 5/20 0.49
▸ L3MBTL1 Q9Y468 4/20 0.49
▸ RAB9A P51151 4/20 0.49
▸ NPC1 O15118 3/20 0.49
▸ TDP1 Q9NUW8 4/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ KMT2A Q03164 7/20 0.38
▸ MEN1 O00255 5/20 0.38
▸ POLB P06746 1/20 0.38
▸ BRD4 O60885 1/20 0.37
▸ CES2 O00748 1/20 0.37
▸ ACHE P22303 1/20 0.37
▸ CES1 P23141 1/20 0.37
▸ APOBEC3A P31941 1/20 0.37
▸ APOBEC3G Q9HC16 1/20 0.37
▸ THRB P10828 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29883561 1.00 MAPT (0.49) MAPTMAPK1L3MBTL1RAB9ANPC1
SCHEMBL825302 1.00 MAPT (0.49) MAPTMAPK1L3MBTL1RAB9ANPC1
SCHEMBL12107154 0.91 THRB (0.41) MAPTMAPK1L3MBTL1RAB9ANPC1
SCHEMBL2589702 0.91 THRB (0.41) MAPTMAPK1L3MBTL1RAB9ANPC1
SCHEMBL30063008 0.91 MAPT (0.41) MAPTMAPK1L3MBTL1RAB9ANPC1
SCHEMBL1004056 0.88 MAPT (0.41) MAPTMAPK1L3MBTL1RAB9ANPC1
SCHEMBL1004057 0.88 MAPT (0.41) MAPTMAPK1L3MBTL1RAB9ANPC1
SCHEMBL1003967 0.88 MAPT (0.40) MAPTMAPK1L3MBTL1RAB9ANPC1
SCHEMBL1003965 0.88 MAPT (0.40) MAPTMAPK1L3MBTL1RAB9ANPC1
SCHEMBL10001950 0.87 THRB (0.36) MAPTMAPK1L3MBTL1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2564245-B1 INTRAOCULAR LENSES WITH COMBINATIONS OF UV ABSORBERS AND BLUE LIGHT CHROMOPHORES ALCON INC (CH) 2021-01-27 — — EP claimed
EP-2451875-B1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS NOVARTIS AG (CH) 2013-08-28 — — EP claimed
EP-2564245-A1 INTRAOCULAR LENSES WITH COMBINATIONS OF UV ABSORBERS AND BLUE LIGHT CHROMOPHORES Novartis AG (CH) 2013-03-06 — — EP claimed
US-8262948-B2 Intraocular lenses with combinations of UV absorbers and blue light chromophores NOVARTIS AG (CH) 2012-09-11 — — US claimed
US-8207244-B2 Visible light absorbers for ophthalmic lens materials NOVARTIS AG (CH) 2012-06-26 — — US claimed
EP-2451875-A2 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS Novartis AG (CH) 2012-05-16 — — EP claimed
WO-2011137142-A1 INTRAOCULAR LENSES WITH COMBINATIONS OF UV ABSORBERS AND BLUE LIGHT CHROMOPHORES NOVARTIS AG (CH) 2011-11-03 — — WO claimed
US-20110266505-A1 INTRAOCULAR LENSES WITH COMBINATIONS OF UV ABSORBERS AND BLUE LIGHT CHROMOPHORES ALCON INC. (CH) 2011-11-03 — — US claimed
WO-2011005713-A2 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS ALCON, INC. (CH) 2011-01-13 — — WO claimed
US-20110003910-A1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS ALCON, INC. (CH) 2011-01-06 — — US claimed
EP-2582409-B1 HIGH REFRACTIVE INDEX, ACRYLIC OPHTHALMIC DEVICE MATERIALS WITH REDUCED GLISTENINGS NOVARTIS AG (CH) 2014-09-10 — — EP disclosed
EP-2451875-B1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS NOVARTIS AG (CH) 2013-08-28 — — EP disclosed
EP-2451875-B1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS NOVARTIS AG (CH) 2013-08-28 — — EP disclosed
EP-2582409-A1 HIGH REFRACTIVE INDEX, ACRYLIC OPHTHALMIC DEVICE MATERIALS WITH REDUCED GLISTENINGS Novartis AG (CH) 2013-04-24 — — EP disclosed
EP-2564245-A1 INTRAOCULAR LENSES WITH COMBINATIONS OF UV ABSORBERS AND BLUE LIGHT CHROMOPHORES Novartis AG (CH) 2013-03-06 — — EP disclosed
WO-2011137142-A1 INTRAOCULAR LENSES WITH COMBINATIONS OF UV ABSORBERS AND BLUE LIGHT CHROMOPHORES NOVARTIS AG (CH) 2011-11-03 — — WO disclosed
WO-2011005713-A2 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS ALCON, INC. (CH) 2011-01-13 — — WO disclosed
US-20110003910-A1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS ALCON, INC. (CH) 2011-01-06 — — US disclosed
US-20110003910-A1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS ALCON, INC. (CH) 2011-01-06 — — US disclosed
US-20110003910-A1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS ALCON, INC. (CH) 2011-01-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003910-A1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS CRY1, CRY2, CRYAA MAPT 557/4885MAPK1 4517/4885L3MBTL1 3116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback